Title : Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib.

Pub. Date : 2021 Aug

PMID : 34595070






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Redifferentiation of BRAF V600E-Mutated Radioiodine Refractory Metastatic Papillary Thyroid Cancer After Treatment With Dabrafenib and Trametinib. Iodine-131 B-Raf proto-oncogene, serine/threonine kinase Homo sapiens